DalsnaFinance › IPOs › Retension Pharmaceuticals › IPO
Retension Pharmaceuticals, Inc. completed its initial public offering on Nasdaq on October 8, 2026.
| Ticker | RTSN |
|---|---|
| Exchange | Nasdaq |
| Status | Completed |
| Listing date | October 8, 2026 |
| Shares offered | 3,750,000 |
| Sector | Pharmaceutical Preparations |
Retension Pharmaceuticals, Inc. listed on Nasdaq on 2026-10-08.
Ingested from SEC EDGAR (424B4, 8-A12B), CIK 2002988.
Retension Pharmaceuticals, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Retension Pharmaceuticals, Inc.. This page is general information, not investment advice.